On Friday, a Trump-appointed federal judge in Amarillo issued a ruling that declared invalid the FDA’s approval of Mifepristone, one of the most commonly used medications used to terminate pregnancies. That ruling appears to place availability of the drug in jeopardy, and a contradictory ruling from another state and the Biden administration’s plan to overturn the the judge’s decision make things even more complicated. What happens next?